FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease that affects predominantly the right ventricle and cause sudden cardiac death. We studied 156 ARVC patients lacking variants in known ARVC genes, and identified two unique FLNCtv variants in two families fulfilling “definite” diagnosis according to the 2010 ARVC Task Force Criteria. Segregation analysis revealed […]

Read More…

Increased TBX6 Gene Dosages Induce Congenital Cervical Vertebral Malformations in Humans and Mice

We previously reported that the human 16p11.2 BP4-BP5 deletion and its associated TBX6 dosage reduction caused congenital vertebral malformations (CVMs) in thoracic and lumber vertebrae. Here we reveal genetic contributions of the reciprocal 16p11.2 BP4-BP5 duplication to cervical CVMs. The spinal assessments in seven duplication carriers showed that four presented characteristics of cervical CVMs. We […]

Read More…

Gene editing prospects for treating inherited retinal diseases

Retinal diseases can result from genetic mutations or combined risk factors, all causing vision impairment progressing to blindness. To date, available therapeutic approaches result in inefficient and expensive treatments. The CRISPR-Cas9 system, an RNA-guided genome editing technology, may be applied to precisely correct or remove disease-related genetic mutations, or induce permanent inhibition of factors promoting […]

Read More…

Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease

All clinical trials for drugs aimed to stop diseases such as Parkinson’s disease and Alzheimer’s disease have failed, and currently there are no drugs that can stop or slow down these diseases. In parallel, we have gathered a lot of data on how genetics affect the risk for these diseases and their clinical progression. However, […]

Read More…

Cardiac valve involvement in ADAR-related type I interferonopathy

The contribution of inflammation to inherited neurological diseases is not well understood. One subgroup of neurological diseases is caused by abnormalities of chemicals known as Type I interferons. We report for the first time heart valve calcification in three children that occurred as a complication of Type I interferon-associated neurodisability caused by mutations in the […]

Read More…

Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY)

People who are born with a pathogenic (disease-causing) variant in the TP53 gene have a very high lifetime risk of developing cancer – almost 100% for women and 75% for men.  The SIGNIFY study, which reported last year, found that whole body Magnetic Resonance Imaging (WB-MRI) in people known to carry a pathogenic variant in […]

Read More…

Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach

Cornelia de Lange syndrome (CdLS) is a rare disease characterized by facial dysmorphism, pre- and postnatal growth retardation, cognitive impairment, gastrointestinal malformations, congenital heart abnormalities and limb defects. CdLS results from nucleotide changes in genes belonging to the cohesin pathway, involved in many biological processes important for cell life. CdLS cells show several dysregulated pathways, […]

Read More…

Homozygous mutations in REC114 cause female infertility characterised by multiple pronuclei formation and early embryonic arrest

Abnormal pronuclear formation during fertilization and subsequent early embryonic arrest result in female infertility. In recent years, a few genes have been identified that are involved in female infertility caused by abnormalities in oocyte development, fertilization, and embryonic development. However, the genetic factors responsible for multiple pronuclei formation during fertilization and early embryonic arrest remain […]

Read More…